MYRIAD GENETICS, INC. Cost of Revenue
MYRIAD GENETICS, INC. (MYGN) reported Cost of Revenue of $36.80 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2018-05-09
- MYRIAD GENETICS, INC. cost of revenue for the quarter ending 2018-03-31 was $36.80M, a 2.90% decline year-over-year.
- MYRIAD GENETICS, INC. cost of revenue for the quarter ending 2017-12-31 was $37.70M, a 0.80% increase year-over-year.
- MYRIAD GENETICS, INC. cost of revenue for the quarter ending 2017-09-30 was $36.20M, a 5.54% increase year-over-year.
- MYRIAD GENETICS, INC. cost of revenue for the quarter ending 2017-06-30 was $35.70M, a 4.39% increase year-over-year.
- MYRIAD GENETICS, INC. cost of revenue for fiscal 2017 was $145.20M, a 9.34% increase from fiscal 2016.
- MYRIAD GENETICS, INC. cost of revenue for fiscal 2016 was $132.80M, a 0.00% change from fiscal 2015.
- MYRIAD GENETICS, INC. cost of revenue for fiscal 2015 was $132.80M, a 38.19% increase from fiscal 2014.
- MYRIAD GENETICS, INC. cost of revenue for fiscal 2014 was $96.10M, a 49.22% increase from fiscal 2013.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $36.80M 10-Q · filed 2018-05-09 | $74.50M derived: sum of 2 quarters · filed 2018-05-09 | $110.70M 10-Q · filed 2018-05-09 | $146.40M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $37.70M 10-Q · filed 2018-02-07 | $73.90M 10-Q · filed 2018-02-07 | $109.60M derived: sum of 3 quarters · filed 2018-02-07 | $147.50M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-09-30 | $36.20M 10-Q · filed 2017-11-08 | $71.90M derived: sum of 2 quarters · filed 2017-11-08 | $109.80M derived: sum of 3 quarters · filed 2018-05-09 | $147.20M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $35.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $73.60M derived: sum of 2 quarters · filed 2018-05-09 | $111.00M derived: sum of 3 quarters · filed 2018-05-09 | $145.20M 10-K · filed 2017-08-09 | ||||
| 2017-03-31 | $37.90M 10-Q · filed 2018-05-09 | $75.30M derived: sum of 2 quarters · filed 2018-05-09 | $109.50M 10-Q · filed 2018-05-09 | $143.80M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $37.40M 10-Q · filed 2018-02-07 | $71.60M 10-Q · filed 2018-02-07 | $105.90M derived: sum of 3 quarters · filed 2018-02-07 | $139.50M derived: sum of 4 quarters · filed 2018-02-07 | ||||
| 2016-09-30 | $34.30M 10-Q · filed 2017-11-08 | $68.50M derived: sum of 2 quarters · filed 2017-11-08 | $102.10M derived: sum of 3 quarters · filed 2017-11-08 | $136.20M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $34.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $67.80M derived: sum of 2 quarters · filed 2017-08-09 | $101.90M derived: sum of 3 quarters · filed 2017-08-09 | $132.80M 10-K · filed 2017-08-09 | ||||
| 2016-03-31 | $33.60M 10-Q · filed 2017-05-03 | $67.70M derived: sum of 2 quarters · filed 2017-05-03 | $98.60M 10-Q · filed 2017-05-03 | $130.50M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | $34.10M 10-Q · filed 2017-02-08 | $65.00M 10-Q · filed 2017-02-08 | $96.90M derived: sum of 3 quarters · filed 2017-08-09 | $129.90M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | $30.90M 10-Q · filed 2016-11-02 | $62.80M derived: sum of 2 quarters · filed 2017-08-09 | $95.80M derived: sum of 3 quarters · filed 2017-08-09 | $130.90M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | $31.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $64.90M derived: sum of 2 quarters · filed 2017-08-09 | $100.00M derived: sum of 3 quarters · filed 2017-08-09 | $132.80M 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $33.00M 10-Q · filed 2016-05-04 | $33.01M 10-Q · filed 2015-05-06 | $68.10M derived: sum of 2 quarters · filed 2016-05-04 | $100.90M 10-Q · filed 2016-05-04 | $100.86M 10-Q · filed 2015-05-06 | $129.16M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-12-31 | $35.10M 10-Q · filed 2016-02-03 | $35.05M 10-Q · filed 2015-02-04 | $67.80M 10-Q · filed 2016-02-03 | $67.85M 10-Q · filed 2015-02-04 | $96.16M derived: sum of 3 quarters · filed 2016-08-10 | $119.81M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-09-30 | $32.80M 10-Q · filed 2015-11-04 | $32.80M 10-Q · filed 2014-11-05 | $61.06M derived: sum of 2 quarters · filed 2016-08-10 | $84.71M derived: sum of 3 quarters · filed 2016-08-10 | $107.46M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | $28.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $51.91M derived: sum of 2 quarters · filed 2016-08-10 | $74.66M derived: sum of 3 quarters · filed 2016-08-10 | $96.10M 10-K · filed 2016-08-10 | $96.14M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $23.65M 10-Q · filed 2015-05-06 | $46.40M derived: sum of 2 quarters · filed 2015-05-06 | $67.84M 10-Q · filed 2015-05-06 | $86.28M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $22.75M 10-Q · filed 2015-02-04 | $44.19M 10-Q · filed 2015-02-04 | $62.63M derived: sum of 3 quarters · filed 2015-08-12 | $79.10M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $21.44M 10-Q · filed 2014-11-05 | $39.88M derived: sum of 2 quarters · filed 2015-08-12 | $56.34M derived: sum of 3 quarters · filed 2015-08-12 | $71.91M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | $18.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $34.90M derived: sum of 2 quarters · filed 2015-08-12 | $50.47M derived: sum of 3 quarters · filed 2015-08-12 | $64.40M 10-K · filed 2015-08-12 | $64.38M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $16.46M 10-Q · filed 2014-05-07 | $32.03M derived: sum of 2 quarters · filed 2014-05-07 | $45.96M 10-Q · filed 2014-05-07 | $59.83M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | $15.57M 10-Q · filed 2014-02-05 | $29.50M 10-Q · filed 2014-02-05 | $43.37M derived: sum of 3 quarters · filed 2014-08-13 | $56.84M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $13.93M 10-Q · filed 2013-11-12 | $27.80M derived: sum of 2 quarters · filed 2014-08-13 | $41.27M derived: sum of 3 quarters · filed 2014-08-13 | $54.08M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $13.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $27.34M derived: sum of 2 quarters · filed 2014-08-13 | $40.15M derived: sum of 3 quarters · filed 2014-08-13 | $51.45M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | $13.46M 10-Q · filed 2013-05-08 | $26.28M derived: sum of 2 quarters · filed 2013-05-08 | $37.58M 10-Q · filed 2013-05-08 | $49.03M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | $12.81M 10-Q · filed 2013-02-06 | $24.11M 10-Q · filed 2013-02-06 | $35.56M derived: sum of 3 quarters · filed 2013-08-14 | $46.69M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | $11.30M 10-Q · filed 2012-11-09 | $22.75M derived: sum of 2 quarters · filed 2013-08-14 | $33.88M derived: sum of 3 quarters · filed 2013-08-14 | $45.92M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | $11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $22.58M derived: sum of 2 quarters · filed 2013-08-14 | $34.63M derived: sum of 3 quarters · filed 2013-08-14 | $45.64M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | $11.13M 10-Q · filed 2012-05-02 | $23.18M derived: sum of 2 quarters · filed 2012-05-02 | $34.19M 10-Q · filed 2012-05-02 | $45.45M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | $12.05M 10-Q · filed 2012-02-01 | $23.06M 10-Q · filed 2012-02-01 | $34.32M derived: sum of 3 quarters · filed 2012-08-15 | $45.20M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-09-30 | $11.01M 10-Q · filed 2011-11-02 | $22.27M derived: sum of 2 quarters · filed 2012-08-15 | $33.15M derived: sum of 3 quarters · filed 2012-08-15 | $44.24M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-06-30 | $11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $22.14M derived: sum of 2 quarters · filed 2012-08-15 | $33.23M derived: sum of 3 quarters · filed 2012-08-15 | $44.29M 10-K · filed 2012-08-15 | ||||
| 2010-03-31 | $10.88M 10-Q · filed 2011-05-04 | $21.96M derived: sum of 2 quarters · filed 2011-05-04 | $33.02M 10-Q · filed 2011-05-04 | |||||
| 2009-12-31 | $11.08M 10-Q · filed 2011-02-01 | $22.14M 10-Q · filed 2011-02-01 | ||||||
| 2009-09-30 | $11.06M 10-Q · filed 2010-11-03 | |||||||
| 2009-06-30 | $43.27M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |